Insider Transactions in Q2 2015 at Medtronic PLC (MDT)
Insider Transaction List (Q2 2015)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2015
|
Omar Ishrak Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
30,195
-5.43%
|
$2,264,625
$75.52 P/Share
|
|
Jun 10
2015
|
Richard H Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,440
+4.89%
|
$304,640
$57.0 P/Share
|
|
Apr 27
2015
|
Richard H Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,950
+2.02%
|
-
|
|
Apr 27
2015
|
Craig Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
563
+3.46%
|
-
|
|
Apr 27
2015
|
Scott C Donnelly Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,950
+20.79%
|
-
|
|
Apr 27
2015
|
Michael O Leavitt Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,950
+10.11%
|
-
|
|
Apr 27
2015
|
Elizabeth G Nabel Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,230
+40.7%
|
-
|
|
Apr 27
2015
|
Shirley A Jackson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,950
+3.11%
|
-
|
|
Apr 27
2015
|
Randall J Hogan Director |
BUY
Grant, award, or other acquisition
|
Direct |
563
+3.5%
|
-
|
|
Apr 27
2015
|
James T Lenehan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,950
+2.69%
|
-
|
|
Apr 27
2015
|
Denise M Oleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,950
+2.25%
|
-
|
|
Apr 27
2015
|
Kendall J Powell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,950
+4.36%
|
-
|
|
Apr 27
2015
|
Robert C Pozen Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,950
+1.89%
|
-
|
|
Apr 27
2015
|
Preetha Reddy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,950
+15.29%
|
-
|
|
Apr 06
2015
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Open market or private sale
|
Direct |
31,768
-23.87%
|
$2,446,136
$77.39 P/Share
|
|
Apr 06
2015
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Exercise of conversion of derivative security
|
Direct |
35,447
+12.51%
|
$1,949,585
$55.11 P/Share
|